Apr 2, 2025, 01:00 AM by User Not Found

Bio-IT World| In the largest phenome wide association study across diverse population groups, an international team of researchers have identified 254 statistically significant associations between genetically explained height and various diseases. Genetically predicted height was linked with decreased risk of 90 diseases and increased risk of 164 others, most notably atrial fibrillation, and a series of conditions involving mental health and the endocrine system that have not been previously described.

Apr 1, 2025, 11:38 AM by

CluePoints, provider of leading statistical and AI-driven software solutions, has today announced Usama Dar as its new Chief Product and Technology Officer.

Apr 1, 2025, 11:38 AM by

AMP announced a favorable ruling in its lawsuit against the U.S. FDA over the regulation of laboratory-developed test procedures.

Apr 1, 2025, 11:38 AM by

Apr 1, 2025, 11:38 AM by

DoseMe, a leading provider of model-informed precision dosing (MIPD), today announced Inspira has expanded the implementation of the dosing platform to serve the newly acquired Mannington site. Inspira has used DoseMeRx since 2020 and integrates with EHR software for faster, efficient access to patient profiles for overall better quality of care.

Apr 1, 2025, 11:38 AM by

First multiplexed solution introduced with the next-generation Cyto-Mine Chroma platform for more efficient biotherapeutic development Utilizes advanced picodroplet microfluidics technology to integrate analysis of antibody productivity and cell viability of monoclonal antibody producing cells

Mar 28, 2025, 01:00 AM by User Not Found

Bio-IT World| Finalists have been named for the 2025 Bio-IT World Best of Show Awards program. More than 20 new products will be on display next week at the Bio-IT World Conference & Expo. New products will be on display from Artificial, Boulder BioComputing, Copyright Clearance Center, Chemspace, Dantech Corporation, Discngine, expert.ai, Genomenon, Globus, GRAU DATA, iuvo, Komprise, Orchestra Bio, Quantum Corporation, QuartzBio, Sinequa, Tech Mahindra, TetraScience, The Hyve, and Velsera.

Mar 27, 2025, 08:13 AM by

Mar 27, 2025, 08:13 AM by

Andaman7, the platform transforming healthcare communications and bridging the gap between patients and researchers, is seeking investment to reach the next milestones in its ground-breaking journey.

Mar 27, 2025, 08:12 AM by

Mayo Clinic Laboratories and Amprion announced a strategic collaboration to expand access to Amprion’s SAAmplify™–αSYN (CSF) test across the U.S.

Mar 27, 2025, 01:00 AM by User Not Found

Bio-IT World| The Pistoia Alliance launched the next phase of its project to measure and reduce the carbon footprint of clinical trials; the Lupus Research Alliance announced the inaugural recipients of the new Targeted Research Program on Engineered Cell Therapies for Lupus; and more.

Mar 26, 2025, 01:00 AM by User Not Found

Bio-IT World| Arbor Biotechnologies will advance its pipeline of novel gene editing therapeutics targeting diseases in the liver and central nervous system; Ataraxis AI will further the development of Ataraxis Breast, the world’s first AI-native prognostic/predictive platform for breast cancer; and more.

Mar 25, 2025, 08:02 AM by

Mar 25, 2025, 08:02 AM by

DNAnexus announces collaboration with AlidaBio to advance epitranscriptomics research and discovery.

Mar 24, 2025, 08:17 AM by

Anthos Therapeutics, Inc., a business that produces abelacimab (full human monoclonal antibody), a late-stage medication being developed to prevent stroke and systemic embolism in patients with atrial fibrillation, has agreed to be acquired by Novartis. Upon concluding the deal, Novartis will pay $925 million upfront, subject to certain usual adjustments. If certain sales and regulatory milestones are met, Novartis may also pay an additional $2.15 billion.

Mar 21, 2025, 08:30 AM by

European women will soon be able to receive permanent birth control through a non-surgical approach. FemBloc, developed by Femasys, a leading biomedical innovator addressing significant unmet needs in women's health worldwide, announces Conformité Européene (CE) mark certification under the European Union Medical Device Regulation (EU MDR) as the first regulatory approval in the world for the FemBloc® delivery system for non-surgical female permanent birth control.

Mar 21, 2025, 08:30 AM by

Coronado Research has appointed Gary Lyons as EVP Medical Affairs. Gary is a seasoned senior Medical Affairs leader with extensive strategic and operational implementation experience across the industry and product lifecycle.

Mar 20, 2025, 08:28 AM by

The project aims at mechanistic modeling of antibodies to predict pharmacokinetics and target occupancy in cerebrospinal fluid.

Mar 20, 2025, 08:28 AM by

CariGenetics and Oxford Nanopore Technologies have launched the Caribbean Genome Programme, the first large-scale genomic sequencing initiative in the region. This pioneering effort is set to address unmet need in advancing regional genetic research in the Caribbean, providing real-time, high throughput sequencing to address critical health disparities, starting with men’s health.

Mar 20, 2025, 08:28 AM by

InformedDNA has acquired Coriell Life Sciences, a provider of pharmacogenomic services and clinical decision support. The combination significantly expands patient, provider and payor access to a broader range of genetic insights and enables more personalized, data-driven treatment and medication decisions for better outcomes and reduced healthcare costs.